(Q34775943)

4 August 2017

1 reference

title

Guide to the use of proton pump inhibitors in adult patients (English)

1 reference

4 August 2017

author

George Triadafilopoulos

series ordinal

3

object named as

George Triadafilopoulos

0 references

author name string

Vandana Boparai

series ordinal

1

1 reference

4 August 2017

Jaishree Rajagopalan

series ordinal

2

1 reference

4 August 2017

publication date

1 January 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

68

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

925-947

1 reference

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868070-00004

Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868070-00004

Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868070-00004

Spots and clots - leave them or treat them? Why and how to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868070-00004

Zollinger-Ellison syndrome. Current concepts in diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868070-00004

Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868070-00004

Proton pump inhibitor treatment for acute peptic ulcer bleeding

21 January 2018

1 reference

12 December 2020

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial

1 reference

12 December 2020

Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus

1 reference

12 December 2020

Symptom index as a marker of gastro-oesophageal reflux disease

1 reference

12 December 2020

Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers

1 reference

12 December 2020

A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication

1 reference

12 December 2020

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding

1 reference

12 December 2020

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

1 reference

12 December 2020

Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study

1 reference

12 December 2020

Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study

1 reference

12 December 2020

Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage

1 reference

12 December 2020

Cost-effectiveness and long-term impact of Helicobacter pylori 'test and treat' service in reducing open access endoscopy referrals

1 reference

12 December 2020

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole

1 reference

12 December 2020

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

1 reference

12 December 2020

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

12 December 2020

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

12 December 2020

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

1 reference

12 December 2020

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

1 reference

12 December 2020

Classification of dyspepsia and response to treatment with proton-pump inhibitors.

1 reference

12 December 2020

A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

12 December 2020

Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia

1 reference

12 December 2020

Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial

1 reference

12 December 2020

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers

1 reference

12 December 2020

The role of proton pump inhibitors in gastro-oesophageal reflux disease

1 reference

12 December 2020

Omeprazole. Overview and opinion

1 reference

12 December 2020

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease

1 reference

12 December 2020

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

1 reference

12 December 2020

Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.

1 reference

12 December 2020

Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus

1 reference

12 December 2020

Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial

1 reference

12 December 2020

Proton pump inhibitors and their drug interactions: an evidence-based approach

1 reference

12 December 2020

Proximal esophageal pH-metry in patients with 'reflux laryngitis'

1 reference

12 December 2020

Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection

1 reference

12 December 2020

Dyspepsia and dyspepsia subgroups: a population-based study

1 reference

12 December 2020

Review of immediate-release omeprazole for the treatment of gastric acid-related disorders

1 reference

12 December 2020

Endoscopic treatment of gastro-oesophageal reflux disease (GORD): a systematic review

1 reference

12 December 2020

Early heartburn relief with proton pump inhibitors: a systematic review and meta-analysis of clinical trials

1 reference

12 December 2020

Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.

1 reference

12 December 2020

Functional gastroduodenal disorders

1 reference

12 December 2020

Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus

1 reference

12 December 2020

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

1 reference

12 December 2020

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

1 reference

12 December 2020

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

1 reference

12 December 2020

Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole

1 reference

12 December 2020

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

12 December 2020

Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease

1 reference

12 December 2020

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

1 reference

12 December 2020

Comparative results of endoluminal gastroplasty and laparoscopic antireflux surgery for the treatment of GERD.

1 reference

12 December 2020

Endoscopic therapy for Barrett's esophagus

1 reference

12 December 2020

An evidence-based appraisal of reflux disease management--the Genval Workshop Report

1 reference

12 December 2020

Therapeutic endoscopy for nonvariceal gastrointestinal bleeding

1 reference

12 December 2020

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease

1 reference

12 December 2020

Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage

1 reference

12 December 2020

Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia. Best evidence synthesis.

1 reference

12 December 2020

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

1 reference

12 December 2020

Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis

1 reference

12 December 2020

Acute gastrointestinal bleeding in the intensive care unit. The intensivist's perspective

1 reference

12 December 2020

A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

1 reference

12 December 2020

Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors

1 reference

12 December 2020

Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial

1 reference

12 December 2020

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety

1 reference

12 December 2020

Experience with antipeptic agents

1 reference

12 December 2020

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group

1 reference

12 December 2020

Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis

1 reference

12 December 2020

Ear, nose and throat and respiratory manifestations of gastro-esophageal reflux disease: an increasing conundrum

1 reference

12 December 2020

Prophylactic therapy for stress ulcer bleeding: a reappraisal

1 reference

12 December 2020

Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study

1 reference

12 December 2020

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

1 reference

12 December 2020

Refractory heartburn.

1 reference

12 December 2020

On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole

1 reference

12 December 2020

Effectiveness of proton pump inhibitors in nonerosive reflux disease

1 reference

12 December 2020

Antacids, pepsin inhibitors, and gastric cooling in the management of massive upper gastrointestinal haemorrhage

1 reference

12 December 2020

Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.

1 reference

12 December 2020

Empirical trials in treatment of gastroesophageal reflux disease

1 reference

12 December 2020

Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease

1 reference

12 December 2020

Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole

1 reference

12 December 2020

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

1 reference

12 December 2020

Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer

1 reference

12 December 2020

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

1 reference

12 December 2020

Paradigm Shift in the Management of Gastroesophageal Reflux Disease

1 reference

12 December 2020

Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.

1 reference

12 December 2020

Omeprazole before endoscopy in patients with gastrointestinal bleeding

1 reference

12 December 2020

Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.

1 reference

12 December 2020

Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.

1 reference

12 December 2020

A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients

1 reference

12 December 2020

Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome

1 reference

12 December 2020

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

12 December 2020

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

1 reference

12 December 2020

Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole.

1 reference

12 December 2020

Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis

1 reference

12 December 2020

Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn

1 reference

12 December 2020

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study

1 reference

12 December 2020

Acid and bile reflux in Barrett's esophagus: a tale of two evils

1 reference

12 December 2020

Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding

1 reference

12 December 2020

Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial

1 reference

12 December 2020

Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis

1 reference

12 December 2020

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

1 reference

12 December 2020

Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis

1 reference

12 December 2020

Risk assessment after acute upper gastrointestinal haemorrhage

1 reference

12 December 2020

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial

1 reference

12 December 2020

Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors

1 reference

12 December 2020

Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors

1 reference

12 December 2020

Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'.

1 reference

12 December 2020

Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association

1 reference

12 December 2020

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

1 reference

12 December 2020

Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis

1 reference

12 December 2020

Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease

1 reference

12 December 2020

Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications

1 reference

12 December 2020

Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study

1 reference

12 December 2020

Clinical efficacy of pantoprazole compared with ranitidine

1 reference

12 December 2020

Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.

1 reference

12 December 2020

Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression

1 reference

12 December 2020

Management of Barrett's esophagus with and without dysplasia

1 reference

12 December 2020

Omeprazole for the treatment of posterior laryngitis

1 reference

12 December 2020

Symptoms in gastro-oesophageal reflux disease

1 reference

12 December 2020

A cost-effectiveness analysis of stress ulcer prophylaxis

1 reference

12 December 2020

Functional heartburn: the stimulus, the pain, and the brain

1 reference

12 December 2020

Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high

1 reference

12 December 2020

Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis

1 reference

12 December 2020

A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage.

1 reference

12 December 2020

The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting

1 reference

12 December 2020

Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.

1 reference

12 December 2020

Treatment of Helicobacter pylori infection. Indications and regimens: an update

1 reference

12 December 2020

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

1 reference

12 December 2020

Long-term proton pump inhibitor therapy and risk of hip fracture

1 reference

12 December 2020

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

1 reference

12 December 2020

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

1 reference

12 December 2020

10.2165/00003495-200868070-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1008006046

0 references

1 reference